Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Halle (Saale) – page 77

1 023 clinical trials in Halle (Saale), Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Halle (Saale) at a glance
1 023
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 023 trials in Halle (Saale)

Open in trial search

Study Comparing Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndrome Who Are Not Dependent on Blood Transfusions

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Epoetin Alfa
  • Sponsor:Celgene Corp.

Study on the Safety and Effects of Favezelimab and Pembrolizumab for Patients with Blood Cancers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Dermatitis atopic

Not recruiting

Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
  • Sponsor:Leo Pharma A/S

IgA nephropathy

Not recruiting

Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ISIS 696844
  • Sponsor:F. Hoffmann-La Roche AG

Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Universitaetsklinikum Tuebingen AöR

Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sacituzumab Govitecan
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Plasma cell myeloma

Not recruiting

Study on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:F. Hoffmann-La Roche AG

Study Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Colitis ulcerative

Not recruiting

Study on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Crohn's disease

Not recruiting

Study on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ropeginterferon ALFA-2B
  • Sponsor:Aop Orphan Pharmaceuticals GmbH

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Halle (Saale)

What the registry says about research in the country

01 Oncology and Hematologic Malignancies

Clinical research in Halle (Saale) is strongly focused on cancer and blood disorders, with studies exploring new treatment options for solid tumors and leukemia, lymphoma, and related conditions.

  • Neoplasms and hematologic malignancies
  • Acute myeloid leukemia, lymphoma, and multiple myeloma
  • Testing newer combinations and more effective treatment strategies
  • Evaluating outcomes in advanced, relapsed, or high-risk disease

Many studies in this area aim to improve survival, disease control, and treatment options for patients with limited standard choices.

02 Lung and Respiratory Diseases

Another major research area covers respiratory tract diseases, especially non-small cell lung cancer, small cell lung cancer, and chronic lung conditions such as COPD and pulmonary fibrosis.

  • Non-small cell lung cancer and small cell lung cancer
  • Chronic obstructive pulmonary disease, bronchiectasis, and idiopathic pulmonary fibrosis
  • Assessing new therapies and maintenance approaches
  • Improving symptom control and long-term respiratory outcomes

The studies often focus on better disease management for both advanced cancers and chronic inflammatory lung disease.

03 Gastroenterology and Inflammatory Bowel Disease

Trials in digestive system diseases and immune-related disorders include important work on Crohn’s disease, ulcerative colitis, and other inflammatory conditions of the gut.

  • Crohn’s disease and ulcerative colitis
  • Coeliac disease and gastrointestinal inflammation
  • Studying new immune-targeted treatments
  • Improving control of active disease and remission rates

These projects aim to reduce symptoms, support remission, and improve quality of life for people with chronic intestinal disease.

04 Cardiovascular and Stroke Research

Cardiovascular diseases are represented by studies on heart failure, atrial fibrillation, stroke, and related complications after surgery or acute vascular events.

  • Heart failure and atrial fibrillation
  • Acute ischemic stroke and vascular occlusion
  • Testing ways to prevent complications and improve recovery
  • Evaluating safer and more effective cardiovascular care

Research in this field is aimed at lowering risk, improving emergency treatment, and supporting long-term heart and brain health.

05 Autoimmune and Immune-Mediated Disorders

Halle’s trial portfolio includes a broad set of studies on immune system diseases, including rheumatologic, skin-related, and other inflammatory conditions.

  • Lupus erythematosus, hidradenitis suppurativa, and giant cell arteritis
  • Atopic dermatitis and chronic spontaneous urticaria
  • Exploring immune-modulating therapies
  • Looking to reduce inflammation and improve daily functioning

These studies reflect a strong interest in better control of chronic immune-driven disease.

06 Hematology, Bone Marrow Transplantation, and Blood Clotting Disorders

A significant share of research addresses myeloid disorders, myeloproliferative neoplasms, and complications linked to stem cell transplantation.

  • Myelodysplastic syndromes, myelofibrosis, and essential thrombocythemia
  • Graft-versus-host disease and transplant-related complications
  • Evaluating better blood cancer and transplant treatments
  • Improving safety and disease control in high-risk patients

Much of this work focuses on patients with difficult-to-treat disease and the need for more precise supportive care.

07 Pediatric Oncology and Rare Childhood Diseases

The city also supports research into children’s cancers and other rare pediatric conditions, including tumors of the brain, blood, and soft tissue.

  • Medulloblastoma, neuroblastoma, and rhabdomyosarcoma
  • Acute lymphoblastic leukemia in children and adolescents
  • Testing more effective and less burdensome treatment approaches
  • Seeking better survival and long-term outcomes for young patients

These trials often aim to refine treatment so that cure rates improve while limiting lasting harm.

08 Neurology and Nervous System Conditions

Research also includes nervous system diseases such as stroke, multiple sclerosis, spinal cord injury, and certain rare neurological disorders.

  • Secondary progressive multiple sclerosis
  • Acute spinal cord injury and idiopathic sudden hearing loss
  • Evaluating therapies that may improve recovery or slow progression
  • Exploring care options for serious and uncommon neurological conditions

These studies are aimed at improving function, symptom relief, and neurological outcomes over time.

09 Metabolic, Kidney, and Endocrine Conditions

Trials in nutritional and metabolic diseases and kidney-related disorders focus on conditions that affect energy balance, organ function, and long-term health.

  • Obesity, metabolic disease, and mitochondrial disease
  • Chronic kidney disease and kidney-related complications
  • Studying ways to slow disease progression
  • Assessing treatments that may improve overall organ health

This area reflects interest in both common chronic illness and rarer inherited disorders.

10 Eye, Ear, and Other Diagnostic Research

Several studies address eye diseases, ear and nose conditions, and broader diagnostic techniques, showing a strong interest in improving how disease is detected and managed.

  • Diabetic macular edema and other vision-threatening eye conditions
  • Hearing loss and otologic disorders
  • Improving diagnosis and monitoring
  • Testing therapies that may preserve vision or sensory function

These projects highlight the role of better diagnostics alongside treatment development in everyday clinical care.

11 Infectious Diseases, Surgery, and Public Health

There is also work on bacterial infections, viral diseases, surgical complications, and public health questions, including prevention and perioperative care.

  • Viral and bacterial infections
  • Surgical bleeding, infection prevention, and post-operative complications
  • Evaluating supportive treatments and preventive strategies
  • Improving safety in hospital and surgical settings

These trials focus on practical clinical needs, from infection control to safer recovery after procedures.

12 Psychiatry and Behavioral Health

Some research in Halle addresses mental disorders and behavioral disciplines, reflecting interest in both emotional health and broader patient well-being.

  • Attention deficit hyperactivity disorder and borderline personality disorder
  • Studying approaches that may improve symptoms and functioning
  • Supporting better understanding of complex behavioral conditions
  • Exploring patient-centered care in mental health

These studies contribute to broader clinical research beyond traditional somatic disease areas.

13 Women’s Health, Fertility, and Urogenital Disorders

Trials also include female and male urogenital diseases, pregnancy-related issues, and fertility-related concerns, showing a balanced interest in reproductive health.

  • Pregnancy complications and vaginal infections
  • Infertility and urogenital disorders
  • Testing therapies for symptom relief and prevention
  • Improving health outcomes for women and men

These studies often aim to make everyday gynecologic and reproductive care more effective.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.